Funding for this research was provided by:
National Natural Science Foundation of China (81472388, 81672534)
Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology ([2013]163)
Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes (KLB09001)
Guangdong Science and Technology Department (2013B021800110, 2015B050501004)
Guangdong Natural Science Foundation (2014A030310133)
Article History
Received: 4 October 2018
Accepted: 7 December 2018
First Online: 3 January 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from each patient on the day of admission.